MA53280A - Composés utiles dans la thérapie du vih - Google Patents

Composés utiles dans la thérapie du vih

Info

Publication number
MA53280A
MA53280A MA053280A MA53280A MA53280A MA 53280 A MA53280 A MA 53280A MA 053280 A MA053280 A MA 053280A MA 53280 A MA53280 A MA 53280A MA 53280 A MA53280 A MA 53280A
Authority
MA
Morocco
Prior art keywords
useful compounds
hiv therapy
hiv
therapy
compounds
Prior art date
Application number
MA053280A
Other languages
English (en)
Inventor
La Rosa Martha Alicia De
John Franklin Miller
B Narasimhulu Naidu
Lita Suwandi
David Temelkoff
Emile Johann Velthuisen
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Viiv Healthcare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd, Viiv Healthcare Co filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of MA53280A publication Critical patent/MA53280A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
MA053280A 2018-08-09 2019-08-08 Composés utiles dans la thérapie du vih MA53280A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862716494P 2018-08-09 2018-08-09

Publications (1)

Publication Number Publication Date
MA53280A true MA53280A (fr) 2021-11-17

Family

ID=68072882

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053280A MA53280A (fr) 2018-08-09 2019-08-08 Composés utiles dans la thérapie du vih

Country Status (15)

Country Link
US (1) US20220117993A1 (fr)
EP (1) EP3833437A1 (fr)
JP (1) JP2021534112A (fr)
KR (1) KR20210044806A (fr)
CN (1) CN112789085A (fr)
AR (1) AR115936A1 (fr)
AU (1) AU2019317810A1 (fr)
BR (1) BR112021002169A2 (fr)
CA (1) CA3108635A1 (fr)
CL (1) CL2021000329A1 (fr)
IL (1) IL280660A (fr)
MA (1) MA53280A (fr)
MX (1) MX2021001612A (fr)
TW (1) TW202023650A (fr)
WO (1) WO2020031131A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3914604B1 (fr) 2019-01-25 2026-03-04 Brown University Compositions comprenant du censavudine ou de l'elvucitabine pour le traitement de l'inflammation et des troubles associés à l'âge
EA202192433A1 (ru) 2019-03-06 2021-12-28 Глэксосмитклайн Интеллекчуал Проперти (№2) Лимитед Соединения, полезные в терапии вич
BR112022000965A2 (pt) * 2019-07-27 2022-06-14 Brii Biosciences Inc Derivado de adenosina e composição farmacêutica que compreende o mesmo
EP4010349A1 (fr) * 2019-08-08 2022-06-15 GlaxoSmithKline Intellectual Property (No. 2) Limited Dérivés de 4'-éthynyle -2'-désoxyadénosine et leur utilisation en thérapie contre le vih
EP4028020A4 (fr) 2019-09-11 2023-09-27 The Scripps Research Institute Promédicaments antiviraux et formulations de ceux-ci
AR121620A1 (es) * 2020-03-20 2022-06-22 Gilead Sciences Inc Profármacos de nucleósidos 4’-c-sustituidos-2-halo-2’-deoxiadenosina y métodos de preparación y uso de los mismos
CN116801884B (zh) 2021-01-25 2026-02-27 腾盛博药生物科技有限公司 使用腺苷衍生物和衣壳抑制剂的针对hiv的组合疗法
CA3202049A1 (fr) * 2021-01-25 2022-07-28 Brii Biosciences, Inc. Derive d'adenosine et composition pharmaceutique le comprenant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
NZ528270A (en) 2001-03-19 2005-10-28 Ono Pharmaceutical Co Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
CA2502109C (fr) * 2004-03-24 2010-02-23 Yamasa Corporation Derive de 2-haloadenosine avec substitution sur le carbone en position 4'
US20100279969A1 (en) * 2007-05-14 2010-11-04 Rfs Pharma, Llc Azido purine nucleosides for treatment of viral infections
WO2015143712A1 (fr) * 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. Inhibiteurs nucléosidiques substitués en 4' de la transcriptase inverse
MX386992B (es) * 2015-08-10 2025-03-19 Merck Sharp & Dohme Llc Compuestos antivirales de fosfodiamida de éster de beta-aminoácido.
US20190185508A1 (en) * 2017-12-15 2019-06-20 Merck Sharp & Dohme Corp. Deuterated nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
CA3108635A1 (fr) 2020-02-13
MX2021001612A (es) 2021-05-13
JP2021534112A (ja) 2021-12-09
BR112021002169A2 (pt) 2021-05-04
AU2019317810A1 (en) 2021-02-25
WO2020031131A1 (fr) 2020-02-13
AR115936A1 (es) 2021-03-17
EP3833437A1 (fr) 2021-06-16
CL2021000329A1 (es) 2021-09-03
KR20210044806A (ko) 2021-04-23
TW202023650A (zh) 2020-07-01
IL280660A (en) 2021-03-25
US20220117993A1 (en) 2022-04-21
CN112789085A (zh) 2021-05-11

Similar Documents

Publication Publication Date Title
MA55200A (fr) Composés utiles dans la thérapie du vih
MA53280A (fr) Composés utiles dans la thérapie du vih
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
IL283487A (en) Compounds useful in hiv therapy
EP3735463A4 (fr) Agent thérapeutique induisant une cytotoxicité
EP3359100A4 (fr) Utilisation d'un manchon stérile dans la production d'une bouillie chirurgicale
EP3751048A4 (fr) Agent de traitement de fibres
EP3849570A4 (fr) Compositions contenant du plasma sanguin
EP3860585A4 (fr) Compositions thérapeutiques
EP4032455A4 (fr) Dispositif de nettoyage
EP3804549A4 (fr) Vêtement de bain
EP3809933A4 (fr) Dispositif de nettoyage
EP3893380A4 (fr) Onduleur
EP3770951A4 (fr) Sondeur
EP3746155A4 (fr) Ensemble seringue
EP3864058A4 (fr) Composition photodurcissable
EP3335688A4 (fr) Composition dentaire polymérisable
EP4037681C0 (fr) Forme posologique de gel masticable
EP3609963A4 (fr) Composition colorante universelle
EP3980440A4 (fr) Agents anti-inflammatoires
EP3960060A4 (fr) Dispositif de nettoyage
EP3597586A4 (fr) Grue à chenilles
EP3888626A4 (fr) Nettoyant
DK3620208T3 (da) Kanyle